Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans - Wikidata - wikimedia - TriplyDB

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

http://www.wikidata.org/entity/Q29616204

about

Immune mechanisms in malaria: new insights in vaccine development Systems immunology of human malaria Vaccines: from empirical development to rational design Immune mechanisms of protection: can adjuvants rise to the challenge?The past and future of tuberculosis research Zika Virus Infects Human Placental Macrophages Lessons learned in the analysis of high-dimensional data in vaccinomics IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques Some vexations that challenge viral immunology The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine Systems Biology Approach for Cancer Vaccine Development and Evaluation Application of "Systems Vaccinology" to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines Systems biology from virus to humans Utilizing population variation, vaccination, and systems biology to study human immunology New approaches to understanding the immune response to vaccination and infection Advances in structure-based vaccine design Beyond empiricism: informing vaccine development through innate immunity research A Blueprint for HIV Vaccine Discovery Systems biology applied to vaccine and immunotherapy development Approaches to vaccines against Orientia tsutsugamushi Systems biology in vaccine design Strategic applications of gene expression: from drug discovery/development to bedside A systems biology approach to the effect of aging, immunosenescence and vaccine response Vaccine applications of flow cytometry Vaccines for the 21st century The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise Profiling immunity to HIV vaccines with systems biology Systems analysis of West Nile virus infection Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7 Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates Booster dose after 10 years is recommended following 17DD-YF primary vaccination A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization Vaccines: the Fourth Century Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders

P2860

Q21032484-16D2C252-63A8-43F1-AA0A-02E00AE72CB8 Q21032488-13DC1152-3486-45B0-8E99-989FB7856E2A Q21089599-000127B6-4E21-4DC4-A0A4-BBD5EB38E684 Q21245319-E8CBD4CD-464C-4C75-8E75-C29EBA550E01 Q21559415-11B36FDF-64D9-4D4A-8A77-8EF05408183B Q24278525-D32F4A39-DE1B-45B4-8C4E-69367DDC421C Q24289396-9E7159DF-15F4-4A7C-8B3C-4D2CD8A3AC9E Q24630281-11640270-9B98-44B2-9428-050637A9B202 Q24672537-ADD397C5-4A88-4EE8-A99E-45DA2B9393D3 Q26700099-285F5E1D-DDCF-4E9C-8946-8B93108C4D46 Q26767147-31AC9207-DFEA-4AA1-84F9-13264258C6C8 Q26782367-1ACEF2E4-A062-492A-B296-4830D00D429E Q26782580-6649BCF1-8E92-461A-81F2-CB1F7892A356 Q26783957-FF7C610F-E152-4C03-8F54-40A964D7944E Q26798272-F4A7435C-A046-440F-A596-C49BB294D7B3 Q26799374-741187DD-ED79-4017-BF74-CC29D594B9D6 Q26800283-D0B74126-7997-4131-ADD0-C6C532119177 Q26824545-EF918CBF-7683-4E6E-A108-6B670E7744DA Q26824573-7C6D2091-C8F9-45D4-A58C-0B9125898453 Q26829865-3835058F-1630-4B00-AC20-4D1A25FE292D Q26830374-149ACAA0-6E3D-41C8-82F7-84FACB03FDE2 Q26849239-069B50A5-CAB0-47C1-BC24-9D0714603D1B Q26851326-9C47997D-5C5E-4870-BD45-94302343FE81 Q26864172-478FC2CF-F650-4069-B3FB-40C9708D7E94 Q26994749-6FA9FD8B-8DD9-4E6E-BB5D-2AFB12035574 Q27004341-8511EED6-88AB-4C48-BE21-B57AA4D0FFCD Q27007529-06A9152B-1591-4DE3-A0D0-4B4F57BD059B Q27010375-8E225F6D-4F8E-4A2B-9884-AF0D1D30A266 Q27010629-EF72FBCB-413D-426D-B0FF-6A77E4DA2408 Q27012977-75874AE5-229A-49B4-989D-5B1F61C22F48 Q27300788-0A2115CD-5533-407D-9E46-A62993637C71 Q27303669-12867AB2-09F6-427F-A67C-67DC5A5A227C Q27304745-459A9482-2A0D-46BF-861A-879C55B81E61 Q27315168-FCBDAE52-EA1D-49F6-A22B-F4619B719CD6 Q27330115-FF951437-1195-4717-A1C0-E0F11A1114A9 Q27468573-7502F764-B71E-4CD2-A7A8-3DA43515B8BF Q27489724-287CD0F0-E940-4364-B165-17E75C90FC2B Q27489813-4065A469-AF80-428F-9F68-E4E5324B9A8B Q27490454-222E65D3-4F2D-4E37-B55E-53919D745C91 Q27491280-80E96016-4339-438B-92BE-1A12EB809A39

P2860

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

http://www.wikidata.org/entity/Q29616204

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

@ast

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

@en

type

label

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

@ast

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

@en

prefLabel

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

@ast

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

@en

P1433

Q29616204-4DFC1CD4-B358-4BAE-A647-62919512F77D

P1476

Q29616204-17E9AC25-938C-4E7E-901E-2D048D4C1C63

P2093

Q29616204-021569B3-DD87-4A1F-96B9-5A1266828DB3

Q29616204-2FD91994-1236-419D-8FB9-F379FDA74C39

Q29616204-3A27C1F8-474D-43C1-B516-67B5A9547670

Q29616204-3EED578E-B303-4EB3-B3FE-DB8A6EF7D6E1

Q29616204-42B382EE-E6C5-4B6B-A4FE-8D18DCE42F62

Q29616204-44885AC4-4161-48ED-9BED-138BBB313B73

Q29616204-582B35B8-2525-4380-AC43-8FBEDD0C6F48

Q29616204-5A06A6A9-76E7-450E-8581-C3A04B7C1893

Q29616204-63E8D764-7063-4BD5-8C74-091FACC49C34

Q29616204-7C5B5E3B-808D-43BA-BCEF-1DB3FF6A9303

P2860

Q29616204-002B27F4-7C9E-44DE-BD73-77A53CC3FF87

Q29616204-0DDCE88B-3C20-4CCE-B95D-3AEE2A512E46

Q29616204-11A44887-8C1D-47FA-8B43-33FA07747782

Q29616204-14D36CC9-2675-4D1E-A75E-22F29360D3A6

Q29616204-17066A01-7C1F-4C91-9EAC-28B231D38737

Q29616204-1FD12553-AD03-47BE-9FE2-143E62099057

Q29616204-269D5F55-602F-4A13-8840-1F247A2CA437

Q29616204-277CD5E6-7A81-42BF-BCC8-0E1092A7AF5E

Q29616204-2C22D78B-6F8F-4815-95C3-4BBBD00E752F

Q29616204-327E4B4E-962D-4C12-B214-7A0BC0FFF3DE

P2888

Q29616204-5CDF9BDB-1B9D-4E49-AFD8-2BD517DAC8C7

P304

Q29616204-B64BAF88-D50F-4977-A3FA-28C5A7DB5677

P31

Q29616204-2D3D82E7-5DE5-4943-95CC-AF499D82F140

P3181

Q29616204-9F2A1E8E-0921-4F82-939C-CDA7ACAD87FE

P356

Q29616204-50D86A4F-EB6B-49B4-B9CB-3C1428AAE21A

P407

Q29616204-56DF37CC-B296-4648-AB9B-BF9CFDB4CD41

P433

Q29616204-C63D74D4-DBC7-4806-BD0E-8DC6FB0449AA

P478

Q29616204-860F3827-227C-4710-B48E-F01DC22675EE

P577

Q29616204-823B675B-A6CB-4C45-AB6B-9A49B0E95E6C

P5875

Q29616204-831CC154-4C78-49C0-B50E-EDD88BA2BCC3

P6179

Q29616204-B66C8D36-55B5-428A-9A03-F5DB3EE147CA

P698

Q29616204-A61A3859-F538-4A92-8FDE-553F3D1A8737

P921

Q29616204-9284FF92-D866-4377-9039-5D996D971927

P932

Q29616204-576A4790-D5EF-47EA-9522-BCCA81016F45

P3181

P356

P1433

Nature Immunology

P1476

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

@en

P2093

Aderem A

http://www.w3.org/2001/XMLSchema#string

Ahmed R

http://www.w3.org/2001/XMLSchema#string

Akondy RS

http://www.w3.org/2001/XMLSchema#string

Bennouna S

http://www.w3.org/2001/XMLSchema#string

Cao W

http://www.w3.org/2001/XMLSchema#string

Deng J

http://www.w3.org/2001/XMLSchema#string

Gernert K

http://www.w3.org/2001/XMLSchema#string

Kennedy K

http://www.w3.org/2001/XMLSchema#string

Lee EK

http://www.w3.org/2001/XMLSchema#string

Marzolf B

http://www.w3.org/2001/XMLSchema#string

P2860

Functional properties and genomics of glucose transporters

Changes in immune parameters and their correction in human cases of tick-borne encephalitis

Protective immune responses against West Nile virus are primed by distinct complement activation pathways

Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Signal integration in the endoplasmic reticulum unfolded protein response

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets

BLyS and B cell homeostasis

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

P2888

P304

116-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1001539

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NI.1688

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23493801

http://www.w3.org/2001/XMLSchema#string

P6179

1026562390

http://www.w3.org/2001/XMLSchema#string

P698

19029902

http://www.w3.org/2001/XMLSchema#string

P921

yellow fever virus

P932

4049462

http://www.w3.org/2001/XMLSchema#string